IRIS

Sfoglia per Rivista  EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 9 a 25 di 25
Titolo Data di pubblicazione Autore(i) File
Knowledge and health care resource allocation: CME/CPD course guidelines-based efficacy 1-gen-2012 Braido, F; Comaschi, M; Valle, Ivana; Delgado, L; Coccini, A; Guerreras, P; Stagi, E; Canonica, G W
Looking for immunotolerance: a case of allergy to baker's yeast (Saccharomyces cerevisiae) 1-gen-2005 Pajno, Gb; Passalacqua, G; Salpietro, C; Vita, D; Caminiti, L; Barberio, G
Measurement of nasal IgE in an epidemiological study: assessment of its diagnostic value in respiratory allergy 1-gen-2004 Marcucci, F; Passalacqua, G; Canonica, Gw; Frati, F; Salvatori, S; Di Cara, G; Bernini, M; Barbato, A; Mastrandrea, F; Sensi, Lg
Molecular diagnosis and the Italian Board for ISAC 1-gen-2014 Nettis, E; Bonifazi, F; Bonini, ROBERTA SERAFINA; Di Leo, E; Maggi, E; Melioli, G; Passalacqua, G; Senna, G; Triggiani, M; Vacca, A; Canonica, G W
Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study 1-gen-2012 Braido, Fulvio; Riccio, ANNA MARIA; Rogkakou, A; Massacane, P; Guerra, L; Fumagalli, F; Stagi, E; Balestracci, S; Porcu, A; Canonica, Giorgio
Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs 1-gen-2003 Senna, Ge; Passalacqua, G; Dama, A; Crivellaro, M; Schiappoli, M; Bonadonna, P; Canonica, Gw
Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosis 1-gen-2011 Rossi, Re; Melioli, G; Monasterolo, G; Harwanegg, C; Rossi, L; Canonica, Giorgio; Passalacqua, Giovanni
Specific immunotherapy: still young after one century 1-gen-2005 Canonica, Gw
Sport, immune system and respiratory infections 1-gen-2003 Gani, F; Passalacqua, G; Senna, G; Mosca Frezet, M
Sublingual immunotherapy: certainties, unmet needs and future directions 1-gen-2009 Passalacqua, G; Lombardi, C; Troise, C; Canonica, Gw
Sublingual immunotherapy: no more doubts 1-gen-2005 Passalacqua, G; Lombardi, C; Guerra, L; Compalati, E; Fumagalli, F; Canonica, Gw
The nocebo effect during oral challenge in subjects with adverse drug reactions 1-gen-2008 Lombardi, C; Gargioni, S; Canonica, Gw; Passalacqua, G
The perception of allergen-specific immunotherapy among chest physicians: an Italian survey 1-gen-2014 Lombardi, C; Canonica, Gw; Passalacqua, G
The perception of allergen-specific immunotherapy among Italian general practitioners 1-gen-2012 Lombardi, C; Bettoncelli, G; Canonica, Gw; Passalacqua, G
Vitamin D levels and allergic diseases. An italian cross-sectional multicenter survey 1-gen-2017 Lombardi, C; Passalacqua, Giovanni; Canonica, Giorgio
What do we need to learn to optimize the SLIT alternative? 1-gen-2006 Serra, Hm; Alignani, Do; Passalacqua, G; Canonica, Gw; Correa, Sg
When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation 1-gen-2019 Bagnasco, D; Aloe, T; Sclifo, F; Ferrantino, Mg; Marugo, F; Arcadipane, F; Manfredi, A; Canonica, G; Passalacqua, G
Mostrati risultati da 9 a 25 di 25
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile